![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2024-07-16/avalo-therapeutics-welcomes-chief-medical-officer/?widget=listSection
https://www.globenewswire.com/en/news-release/2024/07/09/2910192/0/en/Avalo-Therapeutics-Announces-Active-IND-for-AVTX-009-an-anti-IL-1%CE%B2-mAb-to-Treat-Hidradenitis-Suppurativa.html
https://www.globenewswire.com/news-release/2024/06/24/2903341/0/en/Avalo-Therapeutics-Announces-Appointment-of-Paul-Varki-as-Chief-Legal-Officer.html
https://www.globenewswire.com/news-release/2024/06/17/2899557/0/en/Avalo-to-Present-at-the-Oppenheimer-Novel-Targets-in-Immunology-Summit.html
https://www.globenewswire.com/news-release/2024/05/13/2880315/0/en/Avalo-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2024/04/02/2855786/0/en/Avalo-Therapeutics-Appoints-Biotech-Leaders-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/03/29/2854834/0/en/Avalo-Reports-2023-Financial-Results-and-Provides-Business-Updates.html
https://www.fiercebiotech.com/biotech/avalo-signals-change-fortunes-snapping-almatabio-its-ex-lilly-inflammatory-drug
https://www.globenewswire.com/news-release/2024/03/27/2853595/0/en/Avalo-Acquires-Anti-IL-1%CE%B2-mAb-and-Announces-Private-Placement-Financing-of-up-to-185-Million.html
https://www.globenewswire.com//news-release/2023/12/27/2801310/0/en/Avalo-Therapeutics-Announces-1-for-240-Reverse-Stock-Split.html